Scott W Morrison is Director of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 3,350 shares of TARS, which is worth approximately $138,690. The most recent transaction as insider was on Jun 13, 2025, when has been sold 3,350 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.35K
Infinity% 3M change
28.46% 12M change
Total Value Held $138,690

Scott W Morrison Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2025
BUY
Exercise of conversion of derivative security
-
3,350 Added 50.0%
3,350 Common Stock
Sep 30 2024
SELL
Bona fide gift
-
6,016 Reduced 100.0%
0 Common Stock
Sep 15 2024
BUY
Exercise of conversion of derivative security
-
1,333 Added 18.14%
6,016 Common Stock
Jun 24 2024
BUY
Exercise of conversion of derivative security
-
3,350 Added 41.7%
4,683 Common Stock
Sep 15 2023
BUY
Exercise of conversion of derivative security
-
1,333 Added 50.0%
1,333 Common Stock

Also insider at

VERA
Vera Therapeutics, Inc. Healthcare
IDYA
IDEAYA Biosciences, Inc. Healthcare
CRVS
Corvus Pharmaceuticals, Inc. Healthcare
GBT
Global Blood Therapeutics, Inc. Healthcare
ZLAB
Zai Lab Ltd Healthcare
SWM

Scott W Morrison

Director
Burlingame, CA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS